Nephrologists should prioritize routine screening for metabolic markers including uric acid level, lipid profile, and inflammatory biomarkers (CRP, IL-6, TNF-α) in patients with early-stage CKD or those at risk of CKD. Here, CRP is linked to chronic kidney disease.